The pharmaceutical company is mentioned as one of the holdings in the portfolio of an investment fund with strong annual returns.
In passing
August 2026 · 53seconds
Rovi — August 2026
81 analyses
This is a static sample. The live demo updates minute by minute, and Rovi alerts arrive by email in real time as soon as each analysis is ready.
See the live demoRequest early accessThe pharmaceutical company is listed among the firms cited as recipients of investment attracted by Madrid's economic promotion agency.
In passing
The pharmaceutical company appears as one of the Ibex 35 stocks with a percentage decline at the weekly market close.
In passingUnfavourable
The company is mentioned among the notable stocks in the closing of an Ibex 35 trading session.
In passingUnfavourable
The pharmaceutical company is listed among the worst-performing stocks on the Ibex 35 during the session.
In passingUnfavourable
The company is listed among the declining stocks in the Ibex 35 trading session covered in the news.
In passingUnfavourable
The company is listed among the stocks with the largest percentage decline in the Ibex 35 trading session.
In passingUnfavourable
The pharmaceutical company is listed among Ibex 35 stocks with a slight gain at the market's opening session.
In passing
The pharmaceutical company appears as one of the Ibex 35 stocks rising during the daily trading session.
In passingFavourable
The pharmaceutical company appears in a list of Ibex 35 stocks that declined during the daily trading session.
In passingUnfavourable
The pharmaceutical company is mentioned as one of the stocks rising during the Ibex 35 trading session.
In passing
The pharmaceutical company is listed among the Spanish stock index quotes with a slight daily gain.
In passing
The pharmaceutical company is listed as one of the Ibex 35 stocks that posted a slight gain during the trading session.
In passing
The pharmaceutical company appears among the Ibex 35 stocks with the biggest declines in the trading session analyzed.
In passingUnfavourable
The pharmaceutical company is listed as one of the Ibex 35 stocks posting a moderate gain at the market's opening.
In passing
The pharmaceutical company is listed as one of the Ibex 35 stocks with a slight gain at the market opening.
In passing
The pharmaceutical company appears among the stock index securities that posted a slight gain during the trading session.
In passingFavourable
The company appears among the top-gaining stocks in the Ibex 35 trading session.
In passingFavourable
The company is listed among the top-gaining stocks in the Ibex 35 trading session.
In passingFavourable
The pharmaceutical company is listed among the stocks with moderate gains in the Ibex 35 trading session.
In passingFavourable
It is cited as an example of a Spanish pharmaceutical company that is small compared with international peers.
In passing
The pharmaceutical company is listed among the Ibex 35 firms with the largest downward revision in profit margin expectations.
SecondaryUnfavourable
The pharmaceutical company appears in a list of listed companies that made dividend payments during the month of July.
In passing
The pharmaceutical company is listed among several listed firms mentioned for distributing dividends to shareholders in July.
In passing
The pharmaceutical company is listed among the companies that paid dividends to shareholders in July, according to stock market data.
In passing
Its market capitalization is cited as a comparative reference alongside other companies in the Spanish index.
In passing
The pharmaceutical company is cited as a market capitalization reference within the Ibex 35 index.
In passing
The pharmaceutical company is mentioned for its manufacturing agreement with another firm to produce mRNA vaccines in Spain.
SecondaryFavourable
Rovi appears as Moderna's Spanish manufacturing partner linked to the development of mRNA-based therapeutic cancer vaccines.
In the headlineLeading roleFavourable
The pharmaceutical company is mentioned as one of the holdings in an investment fund focused on the healthcare sector.
In passingFavourable
The pharmaceutical company acts as an industrial partner in manufacturing an oncology vaccine developed by another biotech firm.
In the headlineLeading roleFavourable
The pharmaceutical company appears as one of the stocks in the Spanish index with the best weekly performance.
In passingFavourable
The pharmaceutical company appears among the Ibex 35 stocks with the biggest decline during an ordinary trading session.
In passingUnfavourable
Rovi is mentioned tangentially as one of the listed stocks within the overall performance of the Ibex 35 during the described trading session.
In passing
The pharmaceutical company appears as a key manufacturer due to its industrial alliance with the firm developing the vaccine.
In the headlineLeading roleFavourable
The pharmaceutical company is analyzed as one of the IBEX 35 stocks with strong potential due to its expansion in third-party manufacturing.
Leading roleFavourable
The pharmaceutical company appears among the Ibex 35 listed firms with the largest gains during the trading session.
In passingFavourable
The pharmaceutical company appears as the focus of a stock rally linked to a biotech partner's clinical progress.
In the headlineLeading roleFavourable
The pharmaceutical company appears among the top-gaining stocks on the Ibex 35 during a trading session.
In passingFavourable
The company is the subject of the news due to its share price rise linked to its manufacturing partnership with another pharmaceutical firm.
In the headlineLeading roleFavourable
The pharmaceutical company's shares rise following positive clinical trial results from its biotech partner.
SecondaryFavourable
The pharmaceutical company is listed among the stocks with the largest gains on the Spanish stock index that session.
In passingFavourable
The pharmaceutical company appears among the top-gaining stocks in the Ibex-35 trading session covered by the article.
In passingFavourable
The pharmaceutical company is listed among the Ibex 35 firms with the largest gains in the trading session described.
In the headlineIn passingFavourable
The pharmaceutical company is listed among the Ibex 35 stocks with the largest percentage gain in the trading session.
In passingFavourable
The pharmaceutical company is listed among eleven Spanish stocks that analyst consensus does not recommend selling.
In passingFavourable
The pharmaceutical company is listed among eleven Spanish stocks with no sell recommendations according to analyst consensus.
In passingFavourable
The pharmaceutical company appears in a list of Ibex 35 stocks with a slight decline during the trading session.
In passing
The pharmaceutical company appears as one of the Ibex 35 stocks recording declines during the trading session.
In passingUnfavourable
The pharmaceutical company appears among the declining stocks in the trading session of the Spanish benchmark index.
In passing
The company is mentioned as one of the firms reviewed in a sector-wide analysis of first-half results for listed Spanish companies.
SecondaryFavourable
The pharmaceutical company appears among the Ibex 35 stocks with the largest decline at the close of a trading session.
In passingUnfavourable
The pharmaceutical company is listed among the Ibex 35 stocks with slight declines at the start of a trading session.
In passingUnfavourable
The pharmaceutical company appears among the declining stocks of the Ibex 35 during an ordinary trading session.
In passingUnfavourable
The pharmaceutical company is listed as one of the Ibex 35 stocks that declined during the trading session.
In passing
The company is mentioned among Ibex 35 stocks in a report on the performance of the Spanish stock market.
In passing
The pharmaceutical company is listed among the stocks that recorded slight declines at the opening of the Ibex 35 trading session.
In passing
The pharmaceutical company is listed as one of the Ibex 35 stocks declining at the market opening.
In passingUnfavourable
The pharmaceutical company is mentioned as one of the index stocks that recorded a slight decline during the trading session.
In passing
The pharmaceutical company appears in the Ibex 35 stock listing with a slight decline during the session.
In passing
The pharmaceutical company appears in the Ibex 35 stock listing with a slight daily decline in its share price.
In passing
The pharmaceutical company is listed among the IBEX 35 stocks with the worst performance in the trading session.
In passingUnfavourable
The pharmaceutical company appears among the stocks with the largest decline on a day the Spanish stock index reached a historic closing high.
In passingUnfavourable
The pharmaceutical company appears among the Ibex 35 stocks that declined during a session marking a historic close for the index.
In passingUnfavourable
The pharmaceutical company is listed among Spanish firms with vaccine agreements in the US that could be affected by a possible regulatory change.
SecondaryUnfavourable
The pharmaceutical company is the subject of a technical analysis of its recent stock price performance.
In the headlineLeading role
The pharmaceutical company is listed as one of the businesses established in an industrial park, with staff and revenue figures.
SecondaryFavourable
The pharmaceutical company is named among the Ibex 35 stocks identified by analysts as having the greatest potential for share price gains.
SecondaryFavourable
The pharmaceutical company is listed among several Ibex 35 firms cited for strong first-half results.
In passingFavourable
The pharmaceutical company appears among the stocks with moderate gains in a summary of the Ibex 35 trading session.
In passing
The pharmaceutical company is listed among the Ibex 35 stocks posting moderate gains during the trading session.
In passingFavourable
The pharmaceutical company is listed among the top-gaining stocks at the opening of the Ibex 35 trading session.
In passing
The company appears among the stocks with the largest gains in the Spanish stock index during a trading session.
In passing
The pharmaceutical company appears among the top-gaining stocks in the index at the opening of a trading session.
In passing
The pharmaceutical company appears among the top-rising Ibex 35 stocks at the start of a trading session.
In passing
The pharmaceutical company is listed among the Ibex 35 stocks posting losses this year, according to a market analysis.
SecondaryUnfavourable
The pharmaceutical company is mentioned as one of the firms with lower expected dividend yield on the stock index.
In passing
The pharmaceutical company appears among the stocks with a slight decline in a general session of the Spanish market.
In passingUnfavourable
The pharmaceutical company appears among the Ibex 35 stocks showing a slight decline during the trading session.
In passingUnfavourable
The pharmaceutical company is cited as one of the stock index firms with the highest percentage gains this year.
In passingFavourable
The pharmaceutical company is mentioned among the stocks recently added to a wealth management firm's portfolio.
In passingFavourable
This is a static sample. The live demo updates minute by minute, and Rovi alerts arrive by email in real time as soon as each analysis is ready.
See the live demoRequest early accessAnalyses are 53seconds' own wording based on its measurements; no press content is reproduced. Data covers the last 30 days, updated 06-09-2026.